Abnormal Fetal Growth: Aetiology and Management PDF

Summary

This document summarizes abnormal fetal growth, covering aetiology, management, and determinants of birth weight. It details causes, including genetic, chromosomal, and placental issues, as well as maternal factors like reduced utero-placental flow and infections. The document also discusses complications, screening, and prevention strategies associated with abnormal fetal development.

Full Transcript

Summary of ABNORMAL FETAL GROWTH: AETIOLOGY AND MANAGEMENT (Dr Izuka Emmanuel Obiora) Outline: o Determinants of birth weight o IUGR o Macrosomia Determinants of Birth Weight o Gestational age o Maternal size o Fetal gender o Parity o Ethnicity IUGR Introducti...

Summary of ABNORMAL FETAL GROWTH: AETIOLOGY AND MANAGEMENT (Dr Izuka Emmanuel Obiora) Outline: o Determinants of birth weight o IUGR o Macrosomia Determinants of Birth Weight o Gestational age o Maternal size o Fetal gender o Parity o Ethnicity IUGR Introduction: o Defined as a fetus whose:  Estimated weight < 10th percentile for gestational age  Or abdominal circumference < 2.5th percentile Causes: o Fetal:  Genetic  Chromosomal  Congenital malformation  Multiple pregnancy o Placental:  Ischemic placental diseases (ex. placental abruption)  Multiple infarcts  Abnormal cord insertion  Circumvallate placenta  Chorioangioma o Maternal:  Reduced utero-placental flow:  Pre-eclampsia, eclampsia  Renal disease, hypertension, diabetes  Hypoxemia:  Severe anemia, chronic lung disease  Cyanotic heart disease, high altitude  Malnutrition  Substance abuse  Drugs:  Warfarin, anticonvulsants  Beta-blockers, chemotherapy  Infections:  TORCH (esp. CMV)  Others:  Vit D deficiency, ART conception  Radiotherapy, uterine malformation etc. Management: o Screening:  Fetal size estimation by palpation  Symphiso-fundal height (SFH) measurement o Investigations:  Diagnosis is via USS:  Measures fetal biometry, amniotic fluid index (AFI)  Doppler studies of umbilical arteries, cardiotocography (CTG)  Screens for fetal anomalies  Fetal karyotyping  FBC, SEUCr, LFT, urate levels  Antiphospholipid antibodies, TORCH viral studies  Chromosomal studies o Antenatal care:  USS should be done every 2 weeks to measure AFI and do Doppler studies  Estimated fetal weight should be measured every 2 weeks  CTG should be done daily  Give mother steroids  Pregnancy should not exceed 37 weeks GA o Delivery:  Depends on severity of IUGR  If GA is close to term and the fetus is not compromised, induce labor  If there are signs of fetal distress, elective CS is indicated Complications: o Short term:  Hypoglycemia, hypothermia  Hyperviscosity syndrome, birth asphyxia  Impaired immunity, respiratory distress syndrome (RDS)  Necrotizing enterocolitis (NEC) o Long term:  Cerebral palsy, IQ falls  Increased risk of HTN, ischemic heart diseases, hypercholesterolemia etc. in adulthood Prevention: o Stop smoking o Avoid drugs and alcohol o Minimize risk of multiple pregnancy, infections o Treat thrombophilias, treat vit D deficiency o Pre-conception counselling Not effective in prevention: o Bed rest, long-chain fatty acids o Antihypertensives, beta-agonists Macrosomia Introduction: o Birth weight > 4kg Causes: o Constitutional o Genetic disorders:  Beckwith-Wiedemann syndrome, Sotos syndrome  Weaver syndrome, Berardinelli lipodystrophy o Gestational DM o Hyper-insulinemia in non-diabetics Risk factors: o High BMI, excessive weight gain in pregnancy o Multiparity, advanced maternal age o DM, male infant, post-term pregnancy o Previous macrosomic infant, mother was macrosomic at birth Management: o Screening:  Fetal size estimation by palpation  SFH measurement o Diagnosis:  Fetal biometry (biparietal diameter, head circumference, abdominal circumference and femur length)  Use it to calculate estimated fetal weight  The only downside is that USS (which is used for fetal biometry) is less accurate for large babies o Differentials:  Polyhydramnios, multiple pregnancy  Uterine fibroids, pelvic masses  Maternal obesity o Delivery:  CS Complications: o Short term:  Fetal:  Birth trauma, Erb’s palsy  Birth asphyxia, neonatal hypoglycemia  Polycythemia, neonatal jaundice  Respiratory distress syndrome  Maternal:  Genital tract trauma, postpartum hemorrhage  Increased risk of emergency CS o Long term:  Neurodevelopmental delay  Decreased head circumference at 3 years  Increased risk of type 2 DM  Obesity Prevention: o Normalize BMI before conception o Early detection and good control of gestational DM o Moderate exercise during pregnancy

Use Quizgecko on...
Browser
Browser